Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer von Korkeila, E, Talvinen, K, Jaakkola, P M, Minn, H, Syrjänen, K, Sundström, J, Pyrhönen, S

Volltext

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer von Korkeila, E. A., Salminen, T., Kallio, R., Mikkola, M., Auvinen, P., Pyrhönen, S., Ristamäki, R.

Volltext

PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma von Buhmeida, A., Bendardaf, R., Hilska, M., Laine, J., Collan, Y., Laato, M., Syrjänen, K., Pyrhönen, S.

Volltext

BRAF mutations in metastatic melanoma: A possible association with clinical outcome von KUMAR, Rajiv, ANGELINI, Sabrina, CZENE, Kamila, SAUROJA, Ilari, HAHKA-KEMPPINEN, Marjo, PYRHÖNEN, Seppo, HEMMINKI, Kari

Volltext

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer von PYRHÖNEN, S, KUITUNEN, T, NYANDOTO, P, KOURI, M

Volltext

Prognostic factors in prostate cancer von Buhmeida, A, Pyrhönen, S, Laato, M, Collan, Y

Volltext

PO-0947: Breast cancer patientsí knowledge of RT at the beginning of their RT period von Siekkinen, M, Pyrhönen, S, Leino-Kilpi, H

Volltext

Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell Cancer von PYRHÖNEN, S, SALMINEN, E, RUUTU, M, LEHTONEN, T, NURMI, M, TAMMELA, T, JUUSELA, H, RINTALA, E, HIETANEN, P, KELLOKUMPU-LEHTINEN, P.-L

Volltext

PO-0996: Effects of e-feedback knowledge of radiotherapy on breast cancer patients knowledge: A randomized controlled trial von Siekkinen, M, Kesänen, J, Ryhänen, A, Pyrhönen, S, Leino-Kilpi, H

Volltext

Pronounced Tumour Regression after Radiotherapy is Associated with Negative/Weak Glucose Transporter-1 Expression in Rectal Cancer von KORKEILA, E, JAAKKOLA, P. M, SYRJÄNEN, K, PYRHÖNEN, S, SUNDSTRÖM, J

Volltext

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma von Kivelä, T, Suciu, S, Hansson, J, Kruit, W.H.J, Vuoristo, M.-S, Kloke, O, Gore, M, Hahka-Kemppinen, M, Parvinen, L.-M, Kumpulainen, E, Humblet, Y, Pyrhönen, S

Volltext

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial von Joensuu, H., Sailas, L., Alanko, T., Sunela, K., Huuhtanen, R., Utriainen, M., Kokko, R., Bono, P., Wigren, T., Pyrhönen, S., Turpeenniemi-Hujanen, T., Asola, R., Leinonen, M., Hahka-Kemppinen, M., Kellokumpu-Lehtinen, P.

Volltext

Reply: expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer von Korkeila, E, Talvinen, K, Jaakkola, P M, Minn, H, Syrjänen, K, Sundström, J, Pyrhönen, S

Volltext

Comparison of CD44 expression in primary tumours and metastases of colorectal cancer von BENDARDAF, R, ALGARS, A, ELZAGHEID, A, KORKEILA, E, RISTAMÄKI, R, LAMLUM, H, COLLAN, Y, SYRJÄNEN, K, PYRHÖNEN, S

Volltext

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer von Glimelius, B., Ristamäki, R., Kjaer, M., Pfeiffer, P., Skovsgaard, T., Tveit, K. M., Linné, T., Frödin, J. E., Boussard, B., Oulid-Aïssa, D., Pyrhönen, S.

Volltext

Expression of the cell-cell adhesion molecule β-catenin in colorectal carcinomas and their metastases von BUHMEIDA, A., ELZAGHEID, A., ÅLGARS, A., COLLAN, Y., SYRJÄNEN, K., PYRHÖNEN, S.

Volltext

DNA Image Cytometry Predicts Disease Outcome in Stage II Colorectal Carcinoma von BUHMEIDA, A, HILSKA, M, ELZAGHEID, A, LAATO, M, COLLAN, Y, SYRJÄNEN, K, PYRHÖNEN, S

Volltext

Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer von PYRHÖNEN, S, ELLMEN, J, VUORINEN, J, GERSHANOVICH, M, TOMINAGA, T, KAUFMANN, M, HAYES, D. F

Volltext

Thymidylate synthase and microsatellite instability in colorectal cancer: Implications for disease free survival, treatment response and survival with metastases von Bendardaf, R., Lamlum, H., Ristamäki, R., Korkeila, E., Syrjänen, K., Pyrhönen, S.

Volltext

Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future? von Elzagheid, A, Kuopio, T, Pyrhönen, S, Collan, Y

Volltext